Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19003326 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES AND CONDITIONS INCLUDING ECZEMA | December 2024 | May 2025 | Allow | 4 | 0 | 1 | Yes | No |
| 17915306 | PHARMACEUTICAL COMPOSITION COMPRISING NEW LACTOBACILLUS PLANTARUM KC3 STRAIN AND LEONURUS JAPONICUS EXTRACT AS ACTIVE INGREDIENTS FOR PREVENTING OR TREATING RESPIRATORY DISEASE AND USE THEREOF | September 2022 | April 2025 | Allow | 30 | 1 | 1 | Yes | No |
| 17850041 | CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS DERIVED FROM FETAL APPENDAGE, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION | June 2022 | May 2024 | Abandon | 22 | 2 | 0 | Yes | No |
| 17662289 | SMALL MOBILE STEM CELLS (SMS) AND USES THEREOF | May 2022 | August 2024 | Abandon | 27 | 1 | 1 | No | No |
| 17630177 | MUTANT GLUCOSE OXIDASE (GOD) HAVING IMPROVED THERMAL STABILITY AND GENE AND APPLICATION THEREOF | January 2022 | September 2025 | Allow | 43 | 2 | 0 | No | No |
| 17435345 | METHODS AND MATERIALS FOR BIOLOGICAL IMMOBILIZATION IN MICROFLUIDICS | August 2021 | April 2024 | Abandon | 32 | 1 | 1 | No | No |
| 17428510 | PROBIOTIC COMPOSITIONS COMPRISING LACTOBACILLUS REUTERI STRAINS AND METHODS OF USE | August 2021 | August 2025 | Allow | 49 | 2 | 0 | No | No |
| 17328089 | BREVUNDIMONAS STRAIN AS ENDOSYMBIONT OF VERTICILLIUM DAHLIAE AND USE THEREOF | May 2021 | July 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17245935 | METHODS AND MATERIALS FOR TREATING NERVE INJURIES AND NEUROLOGICAL DISORDERS | April 2021 | April 2024 | Abandon | 36 | 2 | 1 | No | No |
| 17219986 | DUAL-MODALITY NANOPROBE TARGETING GLIOBLASTOMA AND PREPARATION METHOD THEREOF | April 2021 | June 2023 | Abandon | 26 | 2 | 0 | No | No |
| 17199376 | SYSTEM AND METHOD FOR EXTRACTION AND CRYOPRESERVATION OF BONE MARROW | March 2021 | March 2024 | Abandon | 36 | 2 | 0 | No | No |
| 17155135 | FloraTummys Probiotic Quick Dissolve Tablet | March 2021 | October 2023 | Abandon | 33 | 1 | 0 | No | No |
| 17172923 | GLYCOSIDE HYDOLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL | February 2021 | May 2024 | Abandon | 39 | 2 | 1 | No | No |
| 17135544 | Compositions and Methods for Treating Inflammatory Bowel Diseases (IBDs) and Other Disorders | December 2020 | October 2023 | Abandon | 33 | 0 | 1 | No | No |
| 17068914 | METHODS FOR DETERMINING A DRUG DOSING REGIMEN | October 2020 | August 2023 | Abandon | 35 | 1 | 0 | No | No |
| 16942724 | Immobilized Enzymatic Digestion of Blood Products for Diagnostic Testing | July 2020 | October 2023 | Abandon | 38 | 1 | 0 | No | No |
| 16900163 | METHOD FOR IDENTIFYING OF A BIOLOGICAL SAMPLE OF A MAMMAL, COMPOSITION FOR USE IN THIS METHOD AND KIT FOR PERFORMANCE OF THIS METHOD | June 2020 | January 2024 | Abandon | 43 | 2 | 0 | No | No |
| 16885323 | SELF-IMMOLATIVE PROBES FOR ENZYME ACTIVITY DETECTION | May 2020 | October 2022 | Allow | 28 | 0 | 0 | No | No |
| 15931772 | METHOD FOR PRODUCING LACTIC ACID AND METHOD FOR PRODUCING POLYLACTIC ACID | May 2020 | January 2023 | Allow | 32 | 1 | 0 | Yes | No |
| 16761811 | ENZYME COMPOSITION FOR SUGAR METABOLIC REGULATION | May 2020 | April 2023 | Abandon | 36 | 3 | 0 | No | No |
| 16760978 | ENGINEERED BACTERIA EXPRESSING RACEMASE FOR TREATING DISEASES ASSOCIATED WITH HYPERAMMONEMIA | May 2020 | December 2022 | Abandon | 32 | 0 | 1 | No | No |
| 16847716 | OPTIMIZED METHOD FOR DECONTAMINATING PRODUCTION OF GLUCOSE POLYMERS AND GLUCOSE POLYMER HYDROLYZATES | April 2020 | June 2023 | Abandon | 38 | 1 | 0 | No | No |
| 16843976 | METHOD FOR PREPARING RHAMNOLIPIDS | April 2020 | October 2021 | Abandon | 18 | 1 | 0 | No | No |
| 16843942 | METHOD FOR PREPARING ACTIVE PROTEIN HYDROLYSATES BY HYDROLYZING CEREAL PROTEINS WITH MALT TOGETHER WITH PROTEASES | April 2020 | October 2021 | Abandon | 18 | 1 | 0 | No | No |
| 16652949 | CELLULAR TRANSPORT SYSTEM FOR TRANSFERRING A SULFONIC ACID CONSTRUCT CARRYING A CARGO INTO THE CYTOPLASM OF A CELL | April 2020 | January 2023 | Allow | 33 | 0 | 1 | Yes | No |
| 16800541 | SYSTEM AND METHOD OF BIOCATALYTIC CONVERSION FOR PRODUCTION OF ALCOHOLS, KETONES, AND ORGANIC ACIDS | February 2020 | March 2023 | Abandon | 37 | 2 | 0 | No | No |
| 16745097 | MULTI-COMPONENT ELECTROSPUN FIBER SCAFFOLDS | January 2020 | January 2023 | Abandon | 36 | 3 | 0 | No | No |
| 16737306 | BLOOD SEPARATION METHOD | January 2020 | December 2023 | Abandon | 47 | 2 | 1 | Yes | No |
| 16705379 | METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION | December 2019 | August 2023 | Abandon | 44 | 3 | 0 | Yes | Yes |
| 16698306 | ELECTROCHEMICAL CONTROL OF REDOX POTENTIAL IN BIOREACTORS | November 2019 | April 2022 | Abandon | 28 | 2 | 0 | No | No |
| 16615164 | ARRANGEMENT, METHOD AND MEASUREMENT INDICATOR FOR UREA DETERMINATION | November 2019 | December 2022 | Abandon | 37 | 0 | 1 | No | No |
| 16674770 | SYSTEM AND METHOD FOR DETECTING NEURAL INJURY | November 2019 | December 2023 | Abandon | 49 | 3 | 0 | Yes | No |
| 16548720 | COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | August 2019 | June 2023 | Abandon | 46 | 2 | 0 | No | No |
| 16469845 | METHOD FOR PROMOTING EXPRESSION OF INSULIN RECEPTOR SUBSTRATE-2 | June 2019 | December 2022 | Abandon | 42 | 2 | 0 | No | No |
| 16342677 | Method, Medium and Kit for Detecting Multiple Aminoglycoside Resistance Including 16S rRNA Methylase Mediated Resistance in Gram-Negative Bacteria | April 2019 | October 2021 | Abandon | 30 | 0 | 1 | No | No |
| 16375919 | Pharmaceutical Compositions Containing Cannabis, Uses Thereof and Methods for Improving Digestion and/or Treating Symptoms Associated with Gastrointestinal Complications | April 2019 | February 2022 | Abandon | 34 | 1 | 1 | No | No |
| 16338017 | METABOLIC RESTRICTION IN CELL-BASED ASSAYS | March 2019 | November 2021 | Abandon | 32 | 2 | 0 | No | No |
| 16336889 | METHODS AND DEVICES | March 2019 | November 2021 | Abandon | 32 | 1 | 1 | No | No |
| 16334670 | METHOD FOR PRODUCING ASTAXANTHIN | March 2019 | November 2021 | Abandon | 32 | 2 | 0 | No | No |
| 16355110 | COMPOSITIONS AND METHODS FOR MONITORING PROGRESSION AND REGRESSION OF DISEASE IN PATIENTS IN RESPONSE TO THERAPY | March 2019 | February 2024 | Abandon | 59 | 8 | 0 | Yes | No |
| 16298695 | Methods for Detecting Microorganisms Using Microorganism Detection Protein and Other Applications of Cell Binding Components | March 2019 | July 2022 | Allow | 40 | 3 | 1 | Yes | No |
| 16284035 | METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS | February 2019 | January 2023 | Allow | 47 | 3 | 1 | Yes | No |
| 16250672 | TWO PHASE SUSTAINABLE PHOTOPRODUCTION VIA CO-CULTIVATION OF ENCAPSULATED, CARBOHYDRATE-PRODUCING CYANOBACTERIA | January 2019 | June 2021 | Abandon | 29 | 1 | 1 | No | No |
| 16303578 | METHODS OF PREVENTING PLATELET ALLOIMMUNIZATION AND ALLOIMMUNE PLATELET REFRACTORINESS AND INDUCTION OF TOLERANCE IN TRANSFUSED RECIPIENTS | November 2018 | December 2022 | Abandon | 49 | 4 | 1 | No | No |
| 16099834 | MESH-BASED IN SITU CROSS-LINKABLE COMPOSITIONS | November 2018 | April 2022 | Abandon | 41 | 2 | 0 | No | No |
| 16085566 | Biofuel generation | September 2018 | October 2020 | Abandon | 25 | 0 | 1 | No | No |
| 16123802 | DIETARY SUPPLEMENTS AND FORMULATIONS | September 2018 | July 2021 | Abandon | 34 | 0 | 0 | No | No |
| 16075059 | New Streptococcal Proteases | August 2018 | June 2023 | Allow | 59 | 4 | 1 | Yes | No |
| 15996916 | Extracellular Matrix-Derived Gels and Related Methods | June 2018 | November 2021 | Abandon | 41 | 0 | 1 | No | No |
| 15735107 | CELLULOSIC BIOFUEL AND CO-PRODUCTS | May 2018 | November 2020 | Abandon | 35 | 1 | 1 | No | No |
| 15903714 | EGG WHITE PROCESSING | February 2018 | June 2023 | Abandon | 60 | 5 | 1 | Yes | No |
| 15795383 | BLOOD COAGULATION ANALYSIS METHOD, BLOOD COAGULATION ANALYZER, AND COMPUTER PROGRAM | October 2017 | November 2018 | Abandon | 13 | 0 | 0 | No | No |
| 15565987 | CROSSLINKED POLYMER STRUCTURE AND USE FOR SAME | October 2017 | April 2021 | Abandon | 42 | 4 | 0 | Yes | No |
| 15724981 | Method for Collecting Rare Cells | October 2017 | November 2018 | Abandon | 14 | 0 | 0 | No | No |
| 15699047 | METHOD OF MAPPING GLYCANS OF GLYCOPROTEINS | September 2017 | March 2021 | Abandon | 42 | 2 | 1 | No | No |
| 15678144 | METHOD OF DETECTING INVASIVE FUNGI ACCORDING TO MORPHOLOGY THEREOF BASED ON CONTRAST STAINING, AND KIT FOR SAME | August 2017 | March 2021 | Abandon | 43 | 2 | 1 | No | No |
| 15675953 | CAPACITIVE BIOSENSOR FOR IDENTIFYING A MICROORGANISM OR DETERMINING ANTIBIOTIC SUSCEPTIBILITY | August 2017 | February 2021 | Abandon | 42 | 3 | 1 | No | No |
| 15550537 | PROCESS COMPRISING SULFUR DIOXIDE AND/OR SULFUROUS ACID PRETREATMENT AND ENZYMATIC HYDROLYSIS | August 2017 | June 2023 | Abandon | 60 | 5 | 1 | Yes | Yes |
| 15633017 | FORMULATIONS FOR WOUND THERAPY | June 2017 | March 2021 | Abandon | 44 | 3 | 0 | No | No |
| 15631530 | MATRIX CONSTRUCTION | June 2017 | October 2019 | Abandon | 27 | 2 | 1 | No | No |
| 15627474 | SYSTEM AND PROCESS FOR LYSING A BIOLOGICAL SAMPLE | June 2017 | October 2020 | Abandon | 40 | 2 | 1 | No | No |
| 15454003 | DIRECTED EVOLUTION USING TURBIDOSTAT FOR INCREASED SPECIFIC GROWTH RATE AND REDUCED LIGHT-HARVESTING ANTENNA SIZE OF PHOTOSYNTHETIC MICROORGANISMS FOR INCREASED PHOTOSYNTHETIC EFFICIENCY | March 2017 | January 2021 | Abandon | 46 | 3 | 1 | No | No |
| 15439650 | PROCESS TO CREATE 3D TISSUE SCAFFOLD USING ELECTROSPUN NANOFIBER MATRIX AND PHOTOSENSITIVE HYDROGEL | February 2017 | July 2020 | Allow | 41 | 3 | 0 | Yes | No |
| 15437948 | CHOLINERGIC ANTAGONISM AS AN ADJUNCT TO CANCER THERAPY | February 2017 | March 2021 | Abandon | 49 | 3 | 1 | No | No |
| 15431530 | Lanthanide-Doped Nanoparticle Compositions for Detecting Microorganisms | February 2017 | February 2021 | Abandon | 48 | 4 | 1 | Yes | No |
| 15323119 | TISSUE MODEL, METHOD FOR PRODUCING SAID TISSUE MODEL, AND USE OF SAID TISSUE MODEL | December 2016 | January 2023 | Abandon | 60 | 6 | 1 | Yes | No |
| 15091715 | BIOLOGICAL SAMPLE MEASUREMENT DEVICE, BIOLOGICAL SAMPLE MEASUREMENT SYSTEM, AND BIOLOGICAL SAMPLE MEASUREMENT METHOD | April 2016 | February 2021 | Abandon | 58 | 6 | 1 | Yes | No |
| 15090019 | METHOD OF MANUFACTURING AN AFOD INTRAVENOUS INJECTION FROM FRACTION IV TO PREVENT AND KILL HIV-1 AND HIV-2 | April 2016 | March 2021 | Abandon | 59 | 2 | 1 | No | No |
| 14925987 | MICROORGANISM CULTURING MATERIAL AND METHOD FOR DETECTING MICROORGANISMS | October 2015 | January 2021 | Abandon | 60 | 4 | 1 | Yes | No |
| 12598047 | MULTIPOTENT STEM CELLS AND USES THEREOF | October 2015 | September 2017 | Abandon | 60 | 5 | 1 | Yes | Yes |
| 14782887 | METHOD AND COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISEASE WITHOUT COLECTOMY | October 2015 | November 2018 | Abandon | 37 | 0 | 1 | No | No |
| 14777397 | USE OF MICROPARTICLES AND ENDOTHELIAL CELLS WITH DECELLULARIZED ORGANS AND TISSUES | September 2015 | November 2020 | Abandon | 60 | 4 | 0 | No | No |
| 14839763 | FERMENTATION SYSTEM FOR DRY MILL PROCESSES | August 2015 | April 2021 | Abandon | 60 | 9 | 0 | Yes | No |
| 14758909 | PROCESSING BIOMASS | July 2015 | March 2021 | Abandon | 60 | 6 | 1 | No | No |
| 14716988 | ENGINEERED STEM CELL THERAPY FOR CARDIAC REPAIR | May 2015 | April 2019 | Abandon | 46 | 2 | 1 | No | No |
| 14684129 | SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | April 2015 | October 2020 | Abandon | 60 | 6 | 0 | Yes | Yes |
| 14573529 | TISSUE TRANSPLANT COMPOSITIONS AND METHODS FOR USE | December 2014 | September 2016 | Abandon | 21 | 1 | 0 | No | No |
| 14550579 | STARCH PROCESS | November 2014 | November 2018 | Abandon | 48 | 1 | 1 | No | No |
| 14548581 | Dedifferentiation and Reprogramming of Cells | November 2014 | April 2017 | Abandon | 28 | 1 | 0 | No | No |
| 14534490 | Method for Producing Hydrocarbons and Oxygen-containing Compounds from Biomass | November 2014 | September 2018 | Abandon | 47 | 2 | 0 | No | No |
| 14398324 | SCAFFOLD | October 2014 | September 2017 | Abandon | 35 | 0 | 1 | No | No |
| 14521583 | Cosmetic Preparations | October 2014 | January 2017 | Abandon | 27 | 1 | 0 | No | No |
| 14473886 | Chymosin for the Prevention and Treatment of Gastrointestinal Disorders | August 2014 | August 2018 | Abandon | 48 | 3 | 0 | No | No |
| 14381503 | TREATMENT OF BIOMASS | August 2014 | September 2018 | Abandon | 49 | 3 | 0 | No | No |
| 14241872 | ISOLATING AND THERAPEUTIC USE OF PERIVASCULAR MEDICINAL CELLS | July 2014 | March 2021 | Abandon | 60 | 5 | 1 | Yes | No |
| 14244761 | PRIMITIVE AND PROXIMAL HEPATIC STEM CELLS | April 2014 | April 2017 | Abandon | 37 | 1 | 1 | Yes | No |
| 14185129 | Body Weight Gain Suppresing Composition and Food Product Comprising the Same | February 2014 | August 2016 | Abandon | 30 | 0 | 1 | No | No |
| 14183599 | Methods for preventing and/or treating nasal polyps and rhinosinusitis | February 2014 | February 2017 | Abandon | 36 | 2 | 1 | No | No |
| 14110230 | AUTOLOGOUS HUMAN ADULT PLURIPOTENT VERY SMALL EMBRYONIC-LIKE (hVSEL) STEM CELL REGENERATION OF BONE AND CARTILAGE | December 2013 | September 2016 | Abandon | 36 | 1 | 1 | No | No |
| 14105698 | Sequential Fermentation of Hydrolsate and Solids from a Dilute Acid Hydrolysis of Biomass to Produce Fermentation Products | December 2013 | August 2016 | Abandon | 33 | 0 | 1 | No | No |
| 14125622 | METHOD FOR PREPARING MICROVESICULAR ADAM15 | December 2013 | August 2016 | Abandon | 33 | 0 | 1 | No | No |
| 14068476 | Method and Composition for Skin Grafts | October 2013 | February 2017 | Abandon | 39 | 1 | 1 | No | No |
| 14002718 | APPARATUS, SYSTEM, AND METHOD FOR CREATING BIOLOGICALLY PROTECTED/ENHANCED SPACES IN VIVO | October 2013 | August 2016 | Abandon | 36 | 0 | 1 | No | No |
| 14051164 | Use of Stem Cells to Reduce Leukocyte Extravasation | October 2013 | June 2024 | Abandon | 60 | 6 | 1 | No | Yes |
| 14040356 | MATERIALS AND METHODS FOR CONVERTING BIOMASS TO BIOFUEL | September 2013 | August 2018 | Abandon | 59 | 6 | 0 | Yes | No |
| 14034353 | Muscodor Albus Strain Producing Volatile Organic Compounds and Methods of Use | September 2013 | October 2018 | Abandon | 60 | 3 | 1 | No | No |
| 14031926 | CONTROLLED PLATELET ACTIVATION TO MONITOR THERAPY OF ADP ANTAGONISTS | September 2013 | October 2017 | Abandon | 49 | 2 | 1 | No | Yes |
| 13799849 | MULTIPOTENT STEM CELLS AND USES THEREOF | March 2013 | September 2017 | Abandon | 55 | 3 | 0 | Yes | Yes |
| 13814823 | PROCESS FOR THE CONVERSION OF BIOMASS OF PLANT ORIGIN, AND A COMBUSTION PROCESS | February 2013 | September 2018 | Allow | 60 | 4 | 1 | No | Yes |
| 13695411 | SCREENING METHODS, COMPOSITIONS IDENTIFIED THEREBY, TOOLS USEFUL FOR THE IDENTIFICATION THEREOF, AND CELL POPULATIONS PRODUCED THEREBY | January 2013 | August 2016 | Abandon | 46 | 3 | 1 | No | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LANDAU, SHARMILA GOLLAMUDI.
With a 20.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 6.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner LANDAU, SHARMILA GOLLAMUDI works in Art Unit 1653 and has examined 129 patent applications in our dataset. With an allowance rate of 10.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.
Examiner LANDAU, SHARMILA GOLLAMUDI's allowance rate of 10.1% places them in the 1% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by LANDAU, SHARMILA GOLLAMUDI receive 2.90 office actions before reaching final disposition. This places the examiner in the 84% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by LANDAU, SHARMILA GOLLAMUDI is 46 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +11.8% benefit to allowance rate for applications examined by LANDAU, SHARMILA GOLLAMUDI. This interview benefit is in the 47% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 2.7% of applications are subsequently allowed. This success rate is in the 1% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 8.5% of cases where such amendments are filed. This entry rate is in the 8% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 57.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 48% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 28.6% of appeals filed. This is in the 3% percentile among all examiners. Of these withdrawals, 75.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 76.9% are granted (fully or in part). This grant rate is in the 82% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.